MedTrace Logo

CRC Detection Reliable Assessment With Blood

NCT05551052 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2025-05-29

No results posted yet for this study

Summary

The CRC DRAW study will assess the sensitivity and specificity of the blood-based, Next-Gen CRC Screening Test for the detection of CRC.

Conditions

  • Colorectal Cancer
  • Adenomas Colon
  • Colon Cancer
  • Rectal Cancer
  • Colon Neoplasm
  • Colon Lesion
  • Colon Disease
  • Colon Polyp
  • Polyps
  • Adenoma
  • Rectal Diseases
  • Rectal Polyp
  • Gastrointestinal Neoplasms
  • Intestinal Neoplasms
  • Colonic Diseases, Functional
  • Intestinal Disease

Interventions

DIAGNOSTIC_TEST

Next-Gen CRC Screening Test

The Next-Gen CRC Screening Test is a blood-based screening test for detection of CRC.

Sponsors & Collaborators

  • New Day Diagnostics

    lead NETWORK

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-08
Primary Completion
2027-10-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05551052 on ClinicalTrials.gov